1. Home
  2. BDTX vs TGL Comparison

BDTX vs TGL Comparison

Compare BDTX & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

N/A

Current Price

$1.44

Market Cap

104.0M

Sector

Health Care

ML Signal

N/A

Logo Treasure Global Inc.

TGL

Treasure Global Inc.

N/A

Current Price

$4.12

Market Cap

2.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BDTX
TGL
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
2.7M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
BDTX
TGL
Price
$1.44
$4.12
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $11.00
N/A
AVG Volume (30 Days)
856.2K
★ 2.0M
Earning Date
11-10-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 130.71
51.53
EPS
N/A
★ 16.03
Revenue
N/A
★ $5,169,784.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$0.23
Revenue Growth
N/A
★ 121.83
52 Week Low
$1.39
$0.14
52 Week High
$4.06
$587.80

Technical Indicators

Market Signals
Indicator
BDTX
TGL
Relative Strength Index (RSI) 36.53 83.93
Support Level N/A $3.79
Resistance Level $1.94 $4.27
Average True Range (ATR) 0.15 0.16
MACD -0.03 0.51
Stochastic Oscillator 3.51 88.35

Price Performance

Historical Comparison
BDTX
TGL

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, a digital rewards and lifestyle platform based in Malaysia that uses artificial intelligence to offer personalized shopping deals, discounts, and rebates, and targets consumers by providing personalized deals based on their purchase history, location, and preferences. The company has two reportable segments: the ZCITY platform, which generates the maximum revenue, and Customized software development service.

Share on Social Networks: